Ep187: Eric Fischer on Creating a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Targeted degraders' potential in cancer and beyond
Luke asks about impact; Eric argues degraders expand target space like antibodies did and can address previously undruggable proteins.
Transcript
Play full episode


